Abbott Laboratories Corporation

Other

Carl Joseph Piontek

Terrence B Mazer

Joseph E Walton

Ronita K Geckle

Bradford Lynn Buck

Robert D Clegg

Matthew S Fleming

William Edward Patton

Andre Daab-Krzykowski

Robert L Joseph

Grant Richard Wilson

William Guy Pierson

Susan Beth Duel

Joseph A Juratovac

Kathryn E Alexander

Thomas D Loughrin

Mark Anthony McCamish

Thomas Walter Osip

Robert Scott Osborne

William Fred Lyon

William H Hirsch

Kent E Iversen

Arthur A Dahl

Rhonda L Cole

Frank A Murawski

Dennis John Hoffman

Jeremy Markham Harris

Gregory James Stephens

Paul Allen Baker

Bonita Kay Geckle

An apparatus for modifying a liquid enteral nutritional product. The apparatus includes a chamber having an inlet and an outlet. The inlet of the chamber is constructed to be fluidly connected to a supply container containing a liquid enteral nutritional. The chamber defines an interior space. The apparatus further includes a retainer disposed in the interior space defined by the chamber. The retainer is constructed to receive one or more dosage form units of beneficial agent therein. The apparatus further includes at least one dosage form unit of beneficial agent retained by the retainer.

Apparatus for altering composition of nutritional product during enteral tube feeding

Apparatus for adding a beneficial agent to a liquid for drinking during oral administration includes a support structure extending transversely across an imperforate walled zone such as the upper end or neck of a bottle or vessel, or of a funnel-like adapter attached to the top of the vessel, with a retention pocket with liquid penetrable walls held by the support structure and comprising at least one beneficial agent secured therein whereby the beneficial agent is taken up in the liquid for drinking during or just prior to oral administration. The beneficial agent may be in either or both of controlled release dosage form or non-controlled release dosage form and may be one or more of nutrients, medicaments, probiotics, electrolytes, rehydration solutions and diagnostic agents, to which a flavoring agent may be added. In the novel method a support structure with a retention pocket comprising at least one beneficial agent is provided in a bottle or vessel with the support structure extending transversely of the neck or top of the bottle or vessel or a drinking tube extending thereinto. The bottle or vessel is provided with a liquid for drinking selected from a liquid nutritional product, a beverage or water and the liquid is contacted with the beneficial agent during or just before oral administration thereof.

Oral administration of beneficial agents

Tubing connector

Fluid delivery set

An apparatus for supplying an enteral or parenteral fluid to a patient is a cooperative assembly of a rotary peristaltic pump and a fluid delivery set. The peristaltic pump has (a) a housing and (b) a peristaltic rotor projecting from the housing on a rotatable drive shaft. The housing has first and second receptacles for retaining and supporting the fluid delivery set. The fluid delivery set has (a) a drip chamber, or sight chamber, (b) a plurality of lengths or segments of flexible tubing, and (c) fluid connection elements therefor. The fluid delivery set defines a fluid pathway from a supply container of the enteral or parenteral fluid to a connector element adapted to be connected to a device for introducing the fluid into the patient. Preferably the fluid delivery set has a tension responsive pinch valve to prevent bolus feeding in the event that the fluid delivery set becomes displaced from the pump housing.

Peristaltic pump and fluid delivery set

Fluid delivery unit

A tubing connector has first and second tubular legs joined together to provide a continuous fluid pathway therethrough with the fluid pathway having a bend of about 78 to 102 degrees therein. A foreshortened retention tab extends laterally from the tubing connector at about the bend in a direction opposed to the second leg of the tubing connector. A handle extends from the tubing connector at about a right angle to both the first and second legs and the retention tab. The tubing connector may be employed as a component of a fluid delivery set used with a pump for enteral or parenteral feeding of a patient.

An apparatus and method are disclosed for modifying a liquid enteral nutritional product during delivery thereof from a supply to a feeding tube delivering the modified liquid enteral nutritional product to the gastrointestinal tract of a patient. At least one beneficial agent not in controlled release dosage form in a useful, dose unit, amount, is disposed within a formulation chamber so as to be taken up in a liquid enteral nutritional product traversing the formulation chamber while feeding the modified nutritional product into the gastrointestinal tract of a patient. The beneficial additive(s) are selected from nutrients, medicaments, probiotics, or diagnostic agents, or mixtures thereof, each in a dosage form that is dispersible in the medium of the liquid enteral nutritional product in less than two hours.

Alteration of nutritional product during enteral tube feeding

An apparatus is useful for dye marking a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient. A formulation chamber, such as a drip chamber, is connectable to the supply container. At least one sustained release reservoir containing a physiologically acceptable marker dye is positioned within the formulation chamber, or if not, is included as part of a kit. The sustained release reservoir may be in the form of a coated tablet, osmotically driven device, coated capsule, microencapsulated microspheres, agglomerated molecular sieving material, or chopped hollow fibers having permeable walls. A liquid communication means connects the formulation chamber to the feeding tube of a patient. The marker dye may be a colorant dye or a fluorescing dye or a mixture thereof. In using the apparatus for dye marking the nutritional product is flowed through the apparatus and a feeding tube to enter the gastrointestinal tract of a patient.

Apparatus for adding marker dye to nutritional product during enteral

A method for dye marking a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient includes the steps of: (1) providing apparatus such as a formulation chamber, e.g., a drip chamber, connectable to the supply container, with at least one sustained release reservoir containing a physiologically acceptable and dispersible marker dye positioned within the formulation chamber, and, liquid communication means connecting the formulation chamber to the feeding tube of a patient; (2) providing a supply container containing the nutritional product; (3) connecting the formulation chamber to the supply container and the liquid commmunication means to the feeding tube; and (4) flowing the dye-marked nutritional product through the apparatus and into the feeding tube. The sustained release reservoir may be a conventional slow release coated tablet, microspheres, or capsule type or an osmotically driven device. The marker dye may be a colorant dye or a fluorescing dye or a mixture thereof. If quick coloration is desired, the sustained release reservoir may be coated with a soluble layer of the marker dye or marker dye not in a sustained release reservoir may be placed in the formulation chamber along with a sustained release reservoir containing dye.

Method of adding marker dye to nutritional product during enternal tube

A method is disclosed for modifying a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient. During enteral tube feeding the nutritional product passes through a formulation chamber, e.g., a drip chamber, having located therein at least one controlled release dosage form unit containing at least one beneficial agent. The beneficial agent may be selected from nutrients, medicaments, probiotics, or diagnostic agents or mixtures thereof, and any such together with a physiologically acceptable marker dye in controlled release dosage form and/or the same or different additional beneficial agent not in controlled release dosage form. Controlled release dosage forms may be of a conventional sustained release type or an osmotically driven delivery device.

Method of altering composition of nutritional product during enteral

An apparatus is disclosed for modifying a liquid enteral nutritional product during delivery thereof from a supply thereof, such as a hangable container, to a feeding tube delivering the liquid enteral nutritional product to the gastrointestinal tract of a patient. The apparatus has at least one formulation chamber, such as a drip chamber, with at least one controlled release dosage form unit in the form of a coated tablet, osmotically driven device, coated capsule, microencapsulated microspheres, agglomerated molecular sieving type material, or a quantity of fine hollow permeable fibers located therein. The controlled release dosage form unit or units contain at least one beneficial agent selected from nutrients, medicaments, probiotics, or diagnostic agents or mixtures thereof, to any of which a physiologically acceptable marker dye in controlled release dosage form and/or the same or different beneficial agent not in controlled release dosage form may be added. A liquid nutritional product flows through the formulation chamber during enteral tube feeding of a patient.

Apparatus for altering composition of nutritional product during enteral

A fluid delivery set has three lengths of flexible tubing. The first length of flexible tubing at one end is connectable to or integral with a supply container for enteral or parenteral fluid, and at the other end is connected to the inlet of a drip chamber. The second length of flexible tubing is connected at one end to the outlet of the drip chamber, and at the other end to the inlet of a retention/connector device that has about a 90.degree. bend therein. The third length of flexible tubing is connected at one end to outlet of the retention/connector device, and at the other end is connectable to or integral with a means for introducing an enteral or parenteral fluid into the body of a patient. Preferably, a tension responsive pinch valve is operatively associated with the second length of flexible tubing.

Growing community of inventors

Powell, OH, United States of America

Carl Joseph Piontek